MAIA Biotechnology, Inc. - Common Stock, par value $0.0001 per share (MAIA)

24 filings reported holding MAIA - MAIA Biotechnology, Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
MAIA Biotechnology, Inc. - Common Stock, par value $0.0001 per share (MAIA) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2.28M shares of 28.9M outstanding shares and own 7.9% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.14M shares), Centric Wealth Management (573K shares), GEODE CAPITAL MANAGEMENT, LLC (222K shares), BlackRock, Inc. (103K shares), STATE STREET CORP (75.6K shares), NORTHERN TRUST CORP (39K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (36K shares), JANE STREET GROUP, LLC (28.8K shares), MARSHALL WACE, LLP (16.2K shares), and Centerpoint Advisory Group (15.7K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.